ROCKVILLE, Md.— New findings show that the medication known as Wegovy® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a study co-authored by past ...
SILVER SPRING, Md.--President-elect of The Obesity Society (TOS) Lee M. Kaplan, MD, PhD, FTOS, has co-authored a new study that describes a newly developed genetic test that can identify newborns at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback